Get the Stockscreener App
1.99
3.65%
0.07
After Hours:
1.99
Shattuck Labs Inc stock is traded at $1.99, with a volume of 237.52K.
It is up +3.65% in the last 24 hours and down -15.32% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$1.92
Open:
$1.95
24h Volume:
237.52K
Relative Volume:
0.11
Market Cap:
$125.67M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-1.0311
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
-3.40%
1M Performance:
-15.32%
6M Performance:
+99.86%
1Y Performance:
+59.20%
1-Day Range:
$1.88
$2.07
1-Week Range:
$1.87
$2.07
52-Week Range:
$0.6922
$2.705
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
1.99 | 91.97M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Will Shattuck Labs Inc. stock reach Wall Street targetsTrade Analysis Report & Fast Moving Stock Trade Plans - newser.com
Identifying reversal signals in Shattuck Labs Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - newser.com
Volume spikes in Shattuck Labs Inc. stock – what they meanJobs Report & Daily Entry Point Trade Alerts - newser.com
Can technical indicators confirm Shattuck Labs Inc.’s reversal2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
Price action breakdown for Shattuck Labs Inc.Swing Trade & Reliable Volume Spike Trade Alerts - newser.com
Is Shattuck Labs Inc. stock attractive for income investorsPortfolio Profit Report & Weekly Hot Stock Watchlists - newser.com
How geopolitical tensions affect Shattuck Labs Inc. stock2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Will Shattuck Labs Inc. stock go up soonJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Visual analytics tools that track Shattuck Labs Inc. performanceJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
Does Shattuck Labs Inc. qualify in momentum factor screeningQuarterly Trade Review & Stock Market Timing Techniques - newser.com
How institutional buying supports Shattuck Labs Inc. stockWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Is Shattuck Labs Inc. stock attractive for retirement portfolios2025 Market Outlook & Smart Money Movement Tracker - newser.com
Short Interest in Shattuck Labs, Inc. (NASDAQ:STTK) Expands By 128.1% - MarketBeat
What moving averages say about Shattuck Labs Inc.Market Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Long term hold vs stop loss in Shattuck Labs Inc.July 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
How to manage a losing position in Shattuck Labs Inc.Weekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
How Shattuck Labs Inc. stock performs during Fed tightening cyclesMarket Growth Summary & Verified Entry Point Detection - newser.com
Shattuck Labs (STTK) Price Target Increased by 15.61% to 2.72 - Nasdaq
How strong is Shattuck Labs Inc. stock balance sheetSwing Trade & Risk Managed Investment Signals - fcp.pa.gov.br
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Performance Recap: How Shattuck Labs Inc. stock benefits from global expansionQuarterly Profit Review & Expert Curated Trade Setup Alerts - fcp.pa.gov.br
Shattuck Labs’ SL-325 Phase 1 Trial: A Key Development in Biopharmaceuticals - TipRanks
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):